Cavitary lung metastases of mixed metaplastic breast cancer mimicking aspergilloma.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 15, p. 1408, doi. 10.1111/1759-7714.14894
- By:
- Publication type:
- Article
Works matching IS 17597706 AND DT 2023 AND VI 14 AND IP 15
Results: 13
1
2
Everolimus in combination with octreotide LAR in thymic atypical carcinoid.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 15, p. 1404, doi. 10.1111/1759-7714.14887
- By:
- Publication type:
- Article
3
Comparative analysis of the efficacy and safety of electromagnetic navigation bronchoscopy combined with x‐ray or radial endobronchial ultrasound biopsy in the diagnosis of small peripheral pulmonary nodules.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 15, p. 1348, doi. 10.1111/1759-7714.14879
- By:
- Publication type:
- Article
4
Prognostic analysis of the plasma fibrinogen combined with neutrophil‐to‐lymphocyte ratio in patients with non–small cell lung cancer after radical resection.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 15, p. 1383, doi. 10.1111/1759-7714.14883
- By:
- Publication type:
- Article
5
RANKL acts an unfavorable prognostic biomarker and potential target in advanced KRAS‐mutated lung adenocarcinoma.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 15, p. 1368, doi. 10.1111/1759-7714.14882
- By:
- Publication type:
- Article
6
Prognostic effect of cachexia in patients with non‐small cell lung cancer receiving immune checkpoint inhibitors.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 15, p. 1362, doi. 10.1111/1759-7714.14881
- By:
- Publication type:
- Article
7
Osimertinib combined with bevacizumab as the first‐line treatment in non‐small cell lung cancer patients with brain metastasis harboring epidermal growth factor receptor mutations.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 15, p. 1355, doi. 10.1111/1759-7714.14880
- By:
- Publication type:
- Article
8
The efficacy and safety of nanoparticle albumin bound‐paclitaxel‐based regimen as second‐ or third‐line treatment in patients with advanced esophageal squamous cell carcinoma.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 15, p. 1392, doi. 10.1111/1759-7714.14885
- By:
- Publication type:
- Article
9
In situ follicular neoplasm discovered as an enlarging pulmonary nodule complicated by pulmonary aspergillosis.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 15, p. 1401, doi. 10.1111/1759-7714.14878
- By:
- Publication type:
- Article
10
Real‐world study of treatment and outcome of type B2 + B3 thymoma: The neglected part of thymoma.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 15, p. 1339, doi. 10.1111/1759-7714.14875
- By:
- Publication type:
- Article
11
Clinical impact of first‐line PD‐1 or PD‐L1 inhibitors combined with chemotherapy in extensive‐stage small cell lung cancer patients: A real‐world multicenter propensity score‐matched study.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 15, p. 1327, doi. 10.1111/1759-7714.14874
- By:
- Publication type:
- Article
12
Multiple micromeningiomas coexist with primary lung adenocarcinoma: A case report.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 15, p. 1398, doi. 10.1111/1759-7714.14872
- By:
- Publication type:
- Article
13
Issue Information.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 15, p. 1325, doi. 10.1111/1759-7714.14501
- Publication type:
- Article